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Abstract: 
Weanling male Sprague-Dawley rats were fed diets for four weeks which differed in their 
content of n-6 (corn oil; CO) and n-3 fatty acids (fish oil; FO), but were similar in their content 
of saturated and monounsaturated fatty acids and vitamin E. At the end of the four-week feeding 
period, each dietary group was subdivided into two groups. One group received a single placebo 
injection of α-tocopherol-stripped corn oil (TSCO); the other group received a single injection of 
the free radical generator, methyl ethyl ketone peroxide (MEKP), in TSCO. Twenty-four hours 
after injection, the effect of dietary oil and MEKP treatment on endogenous lipid peroxide (LPO) 
production (measured as methylene blue formed by the "Determiner LPO" assay), glutathione 
(GSH) and vitamin E content, and fatty acid composition of phosphatidylcholine and 
phosphatidylethanolamine in heart and liver from unfasted animals were measured. FO-fed rats 
had significantly heavier hearts and livers, increased levels of n-3 fatty acids in membrane 
phospholipids, and higher liver LPO levels than CO-fed rats. MEKP treatment resulted in 
significantly lower body weights and liver GSH levels. The data indicate that dietary n-3 fatty 
acids increase lipid peroxidation in liver somewhat more than in heart. The study also 
demonstrates that the effect of induced oxidative stress due to a single dose of MEKP on lipid 
peroxide formation and antioxidant status in tissues from unfasted animals was independent of 
the dietary oils. 
 
Article: 
Dietary supplementation with highly polyunsaturated fats, such as those containing the n-3 fatty 
acids found in fish oil, is associated with an increased tendency for lipid peroxide formation in 
certain tissues (1-3). Lipid peroxidation mediated by free radicals is considered to be a prevalent 
mechanism of cell membrane destruction and cell damage and has been suggested to be 
associated with the initiation and development of atherosclerosis (4). Little is known about how 
the organism responds to an increase in oxidative stress (i.e., activation of free-radical reactions), 
such as lipid peroxidation. In view of the suspected role of oxidative degradation of lipids in the 
etiology of atherogenesis, such information is useful. 
 
Dietary fatty acids influence the composition of membrane phospholipids in heart and liver (5,6). 
Indeed, membrane phospholipids with a high level of polyunsaturated fatty acids (PUFA) are 
more sensitive to hydroxy radicals (7,8). Susceptibility to peroxidation is also influenced by free 
radical scavengers and antioxidants such as vitamin E and glutathione (GSH) (9). Induced 
oxidative stress is accompanied by a decrease in the content of the antioxidants vitamin E and/or 
GSH (10). Further, increased lipid peroxidation is associated with a decrease in liver GSH (11-
13). 
 
In the above experiments, animals were fasted overnight prior to sampling. The standard practice 
to fast animals overnight before drug administration in experimental research is to ensure 
uniform absorption of the test compound. However, deprivation of food and/or water is a 
powerful stressor. Experiments in rats have shown that food deprivation induces alterations in 
free radical-scavenging systems that differ from tissue to tissue (14). Elevated turnover rates of 
liver GSH have been reported during fasting in rats (15). Furthermore, fasting in rats lowers the 
GSH level of the liver without changing its level in the heart (15-17). 
 
Data that indicate that feeding fish oil (FO) induces higher lipid peroxidation in tissues has been 
based on the thiobarbituric acid reactive substances (TBARS) test. This method measures the end 
product, malondialdehyde, which results from the breakdown of lipid peroxides (LPOs) and 
nonlipid compounds. Several investigators have criticized the use of the TBARS test since the 
test is not a reliable index of lipid peroxidation in organ systems (18-20). A preferable procedure 
is to measure LPO levels, using the Determiner LPO assay, a colorimetric method that 
specifically detects hydroperoxides, endoperoxides and peroxy radicals (20,21). 
 
The present study was undertaken to investigate the effects of dietary n-6 and n-3 PUFA and free 
radicals generated by methyl ethyl ketone peroxide (MEKP) on the extent of lipid peroxidation 
and on antioxidant status, i.e., vitamin E and GSH content, in heart and liver tissues of rats. 
MEKP is a toxic, lipid-soluble peroxide that has been shown to rapidly initiate lipid peroxidation 
in vivo and in vitro (22,23). To avoid the possible potentiating effect of fasting on detoxification 
systems, the effect of MEKP on in vivo oxidation processes was studied in unfasted normal 
animals. The lipid peroxidation was measured by a new method, the Determiner LPO assay 
(20,21). 
 
MATERIALS AND METHODS 
Animals and diets.  
Forty-one male weanling Sprague-Dawley rats were obtained from Simonson Laboratories (Los 
Angeles, CA). The rats were housed individually in wire cages under standard conditions of 
22°C, 45% relative humidity, using a 12-h light-dark cycle. The animal care procedures used in 
this study were approved by the Animal Care and Use Committee at Oregon State heavier hearts 
and livers than those fed the CO-rich diet. These differences prevailed when the data were 
expressed on a relative weight basis. The livers of the MEKP-treated rats were lighter than those 
that did not receive the injection, when the data were expressed on a absolute basis but not on a 
relative basis. 
 
The highly polyunsaturated n-6 and n-3 fatty acids in the diets were efficiently incorporated into 
the major classes of membrane phospholipids, phosphatidylcholine (PC) and 
phosphatidylethanolamine (PE; data not shown), of heart and liver. The fatty acid levels of phos-
pholipids in heart and liver were significantly different between the two dietary groups with 
respect to most of the fatty acids analyzed. Pronounced increases in n-3 fatty acids in heart and 
liver membrane phospholipids have been shown repeatedly, and since the effect of the treatment 
and the interaction between the effects of dietary oil and treatment caused minimal changes in 
the fatty acid levels of heart and liver PE, the data from PE are not given here. The interaction 
between dietary oil and treatment was significant in six fatty acids and in the PI of heart PC 
(Table 3) and in two fatty acids of liver PC (Table 4). Within the CO group, MEKP treatment 
significantly decreased the level of 18:2n-6. Within the FO group, the level of 16:0 was 
significantly increased, and the levels of 20:4n-6, 22:5n-3, 22:6n-3 and the PI were significantly 
decreased after a single MEKP injection. MEKP treatment changed the fatty acid levels of liver 
PC only within the CO group, where the levels of 18:1n-9 and 18:2n-6 were decreased. In heart 
PE, there was one interaction where the PI values decreased in MEKP-injected FO-fed rats from 
239.2 ± 3.3% to 221.3 ± 4.3% but remained virtually unchanged in CO-fed rats (148.8 ± 2.0% to 
146.6 ± 4.5%). 
 
The effects of the dietary oils and MEKP treatment on GSH, vitamin E and LPO levels are 
shown in Table 5. Liver GSH was significantly reduced (P < 0.003) by MEKP treatment while 
dietary oils had no effect. Heart GSH was unaffected by dietary oil or MEKP treatment. Liver 
GSH was roughly three times that of the heart. Vitamin E in heart and liver was unaffected by 
dietary oil or MEKP treatment. However, heart vitamin E was roughly twice that in the liver (2 
nmol/mg protein vs. 1, respectively). Liver LPO was significantly higher (P < 0.05) in the FO-
fed group compared to the CO-fed group, while heart LPO was unaffected. MEKP treatment did 
not affect the LPO levels in heart or liver in either of the dietary groups. 
 
Figure 2 shows the relationship between PI in heart PC, vitamin E and LPO levels from rats on 
the FO-diet and being MEKP-treated. The PI was positively correlated with vitamin E levels and 
negatively correlated with LPO levels. 
 
DISCUSSION 
The present study has shown that rats fed n-3 enriched diets do not respond differently to 
induced oxidative stress from a single dose of MEKP as evidenced by LPO formation and 
antioxidant status, compared to rats fed n-6 enriched diets. As anticipated, the injection of MEKP 
stressed the animals, as evidenced by their weight loss within 24 h after injection (Fig. 1). The 
changes in body weight effected by MEKP might be due to loss of appetite and lower food 
intake in addition to metabolic changes. The injection of TSCO or the handling associated with 
the injection was also a stressor, as evidenced by the smaller weight gain experienced by the rats 
after this injection. 
 
 
 
This occurred despite the fact that the rats were handled frequently and that great care was taken 
to assure that the injection was made causing a minimum of discomfort. The data suggest that 
stress can confound results from studies in which animals are subjected to procedures such as an 
injection. 
 
The highly polyunsaturated n-6 fatty acids in CO and n-3 catty acids in FO were efficiently 
incorporated into the major classes of phospholipids, i.e., PC and PE, of heart and liver, which is 
in agreement with previous studies (5,6). The contribution of individual fatty acids to lipid 
peroxidation has been shown to reflect the degree of un saturation of n-3 fatty acids more than 
that of the n-6 type (31). In our study, a single MEKP injection caused significant reduction in 
the levels of PUFA, 20:4n-6, 22:5n-3 and 22:6n-3 of heart PC from FO-fed rats. The interaction 
between dietary FO and MEKP treatment on fatty acid levels was evident to a lesser extent in 
heart PE (data not shown) and liver PC. The fatty acid levels of liver PE (data not shown) were 
unaffected by MEKP in each of the dietary groups. In sarcolemma of myocardial cells, PC is 
preferentially present in the outer monolayer, and PE in the inner (32). The observed reduction in 
the levels of highly PUFA in heart PC could indicate that PC is less 
 
 
protected from oxidation induced by MEKP. The observed changes in fatty acid composition of 
heart phospholipids did not resemble changes induced by stress, i.e., exogenous epinephrine (5). 
Repeated administration of epinephrine caused increased levels of 20:4n-6 and 22:6n-3 in PC, 
decreased or unaltered 20:4n-6 and increased 22:6n-3 in PE and decreased level of 18:2n-6 in PC 
and PE. These changes were qualitatively similar although different dietary fats were used, i.e., 
butter, corn oil or cod liver oil (5). 
 
The phospholipids of heart and liver from the FO-fed rats contain high levels of the highly 
peroxidizable polyunsaturated n-3 fatty acids (Tables 3 and 4) causing the higher PI values. Even 
though the PI of the phospholipids was higher in heart than in liver of FO-fed rats, lipid per-
oxidation was higher in the liver, i.e., the LPO levels were higher in liver than in heart of FO-fed 
rats (Table 5). Vitamin E is thought to act as one of the most important antioxidants in vivo 
because of its role in blocking the propagation of LPO in the membrane. Vitamin E levels in the 
heart were twice those in the liver, and LPO levels were lower in heart than in liver. The 
insensitivity of heart from FO-fed rats to lipid peroxidation could be explained by the high 
vitamin E level, which seems to be sufficient to suppress the in vivo peroxidation of n-3 fatty 
acids in heart phospholipids of normal rats. 
 
Mouri et al. (3) and Chautan et al. (33) showed that the heart vitamin E content dramatically 
increased as the membranes became enriched in n-3 PUFA, whereas liver became depleted of 
vitamin E. However, in our study, no differences in the level of vitamin E in heart or liver were 
found between FO-fed and CO-fed rats (Table 5). The role of vitamin E in preventing the 
oxidative destruction of PUFA in cell membranes has been elusive (34). It has been suggested 
that vitamin E stabilizes the cell membrane through interaction of its phytyl side chains with the 
polyunsaturated fatty acyl groups of phospholipids (35). Vitamin E levels and PUFA contents 
were shown to influence membrane susceptibility to lipid peroxidation, and below a certain 
vitamin E threshold, differences in membrane susceptibility to peroxidation could be reason ably 
predicted based on the content of individual peroxidizable fatty acids only (31). Furthermore, a 
strong positive correlation was found between heart vitamin E and n-3 fatty acids of total lipids 
in heart membranes of rats, which suggests that n-3 PUFA in cell membranes are efficiently 
protected against lipid peroxidation (33). Individual data from this study showed that only after 
an induced peroxidative stress, i.e., a single MEKP injection, was there a positive correlation 
between vitamin E levels and PI values and a negative correlation between LPO levels and PI 
values in hearts from FO-fed rats (Fig. 2). No such correlation was found in hearts from TSCO-
treated rats in either of the dietary groups. 
 
The products of lipid peroxidation are mainly the hydroperoxides of fatty acyl moieties. In the 
present study, the lower levels of highly PUFA of heart PC induced by MEKP are not reflected 
in higher levels of LPO in heart. It is suggested that membrane-bound phospholipase A2 
produces an "antioxidant" effect by excising LPOs from the membrane, thereby preventing them 
from participating in free radical propagation reactions (36). The membrane-bound 
phospholipase A2 is hence considered as one of the scavenger and antioxidant enzymes that act 
to preserve cellular structure and function. 
 
GSH in liver is thought to be used as a cysteine reservoir for GSH synthesis in peripheral organs 
during periods of enhanced consumption or limited supply (37,38) and as a defense mechanism 
against oxidative stress (39). It has been shown that the reduction of GSH levels in liver as a 
consequence of oxidative stress was more pronounced in livers from fasted than from fed rats 
(40). A significant reduction in liver GSH levels was only observed in unfasted rats 24 h after an 
MEKP injection (Table 5). The reduced level of liver GSH was not reflected in an increased 
oxidized level of GSH (GSSG). The liver and heart GSSG levels were less than 1 nmol/mg 
protein in both dietary groups (data not shown). 
 
In summary, the effect of MEKP treatment on GSH levels on the levels of PUFA of membrane 
phospholipids and on tissue weights differed between heart and liver. One should therefore be 
cautious in extrapolating results from one tissue to another. The present results also support the 
idea that in studies on lipid peroxidation and radical-scavenging defense mechanisms, attention 
must be paid to the biochemical changes that are associated with fasting (14,41). In the present 
study, no deleterious effect of increased susceptibility to lipid peroxidation due to the n-3 fatty 
acid-enriched dietary intake was seen in heart and liver of unfasted animals. The reduced levels 
of highly PUFA in heart PC induced by MEKP were not reflected in higher levels of LPO in 
heart from FO-fed rats. The fate of the peroxidized PUFA will require further study. 
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